Addiction

Many hospitals fail to screen for substance use, offer medications to treat opioid use disorder or connect patients to follow-up care.

Time Magazine's Jamie Ducharme on the rise and fall of Juul and how the e-cigarette company went from helping people quit smoking to hooking teens on vaping.

The change impacts people who need addiction treatment and use medical marijuana for a substance use or mental health disorder.

The strips allow people to test other drugs for the presence of fentanyl, a synthetic opioid that has played a major part in driving the country’s rising overdose death toll.

The DA’s of Pennsylvania’s two biggest counties say an opioid settlement deal brokered by Attorney General Josh Shapiro won’t provide enough relief.

GOP lawmakers say they’re still weighing Pennsylvania Gov. Tom Wolf’s request to extend a longstanding disaster declaration to combat the opioid crisis.

In a letter to the General Assembly, Tom Wolf said he plans an Aug. 5 renewal of the disaster emergency declaration first issued in January 2018.

Delaware issues fines to insurers for not treating people with mental health or substance abuse issues as fairly as they treat others.

The complaint effectively asks a state judge to allow an ongoing lawsuit against opioid manufacturers to continue, which the settlement jeopardizes.

After nearly two-and-a-half hours of public comment, the Atlantic City Council voted to no longer allow the needle exchange at the Oasis Drop-in Center to operate.

A settlement involving many states, including Pennsylvania, might not be good enough for city officials.

The CDC reported 5,172 overdose deaths in Pennsylvania last year, a jump of 16% from 4,444 in 2019.

City officials sent a total of $200,000 to 20 community groups dedicated to improving the quality of life in the epicenter of Philadelphia's opioid crisis.

Overdose deaths in 2020 are just one facet of what was overall the deadliest year in U.S. history, with about 378,000 deaths attributed to COVID-19.

Pennsylvania would receive $225 million to fight the opioid-addiction epidemic from a new agreement with OxyContin maker Purdue Pharma.